Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Fun in the Sun: The Benefits of Vitamin D

Samantha C. Shapiro, MD  |  Issue: December 2024  |  November 23, 2024

Interestingly, Dr. Christakos noted that 1,25-dihydroxy-vitamin D suppresses diabetes, experimental autoimmune encephalomyelitis (EAE)—the multiple sclerosis (MS) equivalent in mice—and inflammatory bowel disease (IBD) in mouse models. The mechanisms by which vitamin D ameliorates these diseases remain quite unknown, as well as whether this can reverse the effects of EAE. However, there are tantalizing hints that interleukin 17 (IL-17) may be downregulated by vitamin D treatment, which may be contributory. A separate in vitro study combining 1,25-dihydroxy-vitamin D with interferon-beta also showed a cooperative effect of decreasing IL-17. Unfortunately, human studies have not shown a utility for IL-17 inhibitors for multiple sclerosis.

Dr. Christakos noted that vitamin D and 1,25-dihydroxy-vitamin D can suppress colitis in a genetically predisposed mouse model of IBD. In genetically engineered mice lacking Rab11a, mice treated with 1,25-dihydroxy-vitamin D had restoration of pathologic chances as well as decreased IL-6 and IL-1-beta in the ileum. Although these are mouse models, human beings may have similar mechanisms.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Infection Reduction

Margherita Cantorna, PhD, distinguished professor of molecular immunology at Pennsylvania State University, University Park, also discussed how vitamin D affects immune responses to pathogens. In pregnant women, vitamin D deficiency and VDR deficiencies affect immune progenitors likely through vitamin D signaling. Moreover, vitamin D may have a regulatory effect on the microbiome in neonates. Vitamin D-sufficient animals tend to have more diverse microbes, greater epithelial barrier function and local immune responses. Indeed, vitamin D may help to “regulate the balance between anti- and pro-inflammatory responses” by supporting cells that create IL-10 and decreasing cells that produce IL-17 and interferon gamma.

On a more holistic level, clinical trials have not shown an effect of vitamin D replacement on reducing or preventing respiratory infections. However, raising 25-hydroxyvitamin D (25(OH)D) reduces inflammation, which may help protect the host from infection. In mice models, offspring born to mothers with lower vitamin D have lower VDR levels, which lead to increased susceptibility to influenza. Importantly, supplementation with vitamin D restores vitamin D status but susceptibility to influenza remains.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Altogether, it suggests that vitamin D is a fine-tuner of the immune system, not a hammer.


Samantha C. Shapiro, MD

Samantha C. Shapiro, MD

Samantha C. Shapiro, MD, is a clinician educator who is passionate about the care and education of rheumatology patients. She writes for both medical and lay audiences and practices telerheumatology.

References

  1. Beretich BD, Beretich TM. Explaining multiple sclerosis prevalence by ultraviolet exposure: A geospatial analysis. Multiple Sclerosis. 2009;15(8).
  2. Kriegel MA, Manson JAE, Costenbader KH. Does vitamin D affect risk of developing autoimmune disease? A systematic review. Semin Arthritis Rheum. 2011;40(6).
  3. Manson JE, Cook NR, Lee IM, et al. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380(1).
  4. Hahn J, Cook NR, Alexander EK, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. The BMJ. 2022;376.
  5. Costenbader KH, Cook NR, Lee IM, et al. Vitamin D and marine n-3 fatty acids for autoimmune disease prevention: Outcomes two years after completion of a double-blind, placebo-controlled trial. Arthritis Rheumatol. 2024;76(6).
  6. Zheng R, Gonzalez A, Yue J, et al. Efficacy and safety of vitamin D supplementation in patients with systemic lupus erythematosus: A meta-analysis of randomized controlled trials. Am J Med Sci. 2019;358(2).
  7. Al-Saoodi H, Kolahdooz F, Andersen JR, Jalili M. Effect of vitamin D on inflammatory and clinical outcomes in patients with rheumatoid arthritis: A systematic review and dose–response meta-analysis of randomized controlled trials. Nutr Rev. 2024;82(5).

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsOther Rheumatic ConditionsRheumatoid ArthritisSystemic Lupus Erythematosus Tagged with:ACR Convergence 2024

Related Articles

    Drug Updates

    November 1, 2009

    Information on News Approvals and Medication Safety

    Improve RA Care with Vitamin D

    November 16, 2015

    Background Autoimmune diseases, such as rheumatoid arthritis (RA) and systemic lupus erythema­tous, occur when the body attacks its own tissue because it cannot differentiate between self and non-self. This is mainly through deregulation of the immune system. Vitamin D has been known to play a critical role in bone mineralization and bone health. Activated vitamin…

    Vitamin D in Rheumatology: Cause and Effect Unclear

    September 15, 2015

    The controversy over vitamin D is hearty enough to confuse even seasoned rheumatologists, says Nathan Wei, MD, The Arthritis Treatment Center, Frederick, Md. “It’s like what you hear with coffee. One week, [a study finds] coffee is … good for you; the next week, there’s a study saying it’s bad for you,” he says. ad…

    Clinical Rheumatology Year in Review 2021

    November 22, 2021

    ACR Convergence 2021—On Nov. 5, Karen H. Costenbader, MD, MPH, professor of medicine, Harvard Medical School, and director of the lupus program, Brigham and Women’s Hospital, Boston, gave a whirlwind review of the most important clinical rheumatology publications of the past year. Testing New Medications for Rheumatic Disease ADVOCATE Trial of Avacopan ad goes here:advert-1ADVERTISEMENTSCROLL…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences